ArticleFrontiers in public health2025
Decadal trends and regional disparities in tuberculosis burden: a comprehensive analysis of global, African, and Southeast Asian data from the GBD 1990-2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Advanced statistical approaches in tuberculosis diagnosis and treatment outcomes in Africa: a systematic review.Tropical medicine and health · 2026Review
- Article
- Optimizing Quality of Care for Elderly Tuberculosis Patients in Shanghai, China: Insights from Patient Cascade of Care and Patient Pathway Analysis.Tropical medicine and infectious disease · 2026Article
- A retrospective analysis of tuberculosis notification trends and spatial distribution in South Africa, 2005-2012.Discover public health · 2026Article
- Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction inFrontiers in microbiology · 2026Article
- Molecular links between tuberculosis and lung cancer: pathogenesis and therapeutic challenges.Archives of microbiology · 2025Review
- Applying Multiple Analyses to Quantify Changes in the Global, Regional, and National Burden of Tuberculosis From 1990 to 2021 and the Forecast Until 2035.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025Article
- Tuberculosis infection following administration of immune checkpoint inhibitors: a real world observational study.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB), an infectious disease caused by Methods: Data from the Global Burden of Disease 2021 (GBD 2021) study were used to evaluate TB incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021. Statistical analyses were conducted using R software and Joinpoint Regression Program to identify trends in age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR). The annual percentage change (APC) was calculated to assess the significance of temporal trends. Results: From 1990 to 2021, global age-standardized rates of TB declined markedly, with ASIR decreasing from 173.0 to 103.0 per 100,000, ASMR from 40.0 to 14.0, and ASDR from 1,650.6 to 580.3. Although incident case numbers slightly declined globally, absolute numbers increased in Africa and Southeast Asia, despite reductions in standardized rates. The disease burden has shifted from younger to older age groups, reflecting population aging. Males consistently exhibited a higher burden than females, though sex disparities narrowed over time. Joinpoint regression confirmed sustained declines in all indicators, particularly in Africa and Southeast Asia. Projections to 2040 suggest continued reductions and convergence in burden across regions. Spatial analyses identified persistent high-burden clusters in sub-Saharan Africa and Southeast Asia, despite overall global improvement. Conclusion: TB remains a significant public health issue, especially in Africa and Southeast Asia. While global incidence and mortality have decreased, persistent regional disparities call for more targeted interventions. Ongoing global efforts are essential to further reduce TB-related morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.